vorinostat has been researched along with Gastrointestinal Stromal Tumors in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Gastrointestinal Stromal Tumors: All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mühlenberg, T | 1 |
Zhang, Y | 1 |
Wagner, AJ | 1 |
Grabellus, F | 1 |
Bradner, J | 1 |
Taeger, G | 1 |
Lang, H | 1 |
Taguchi, T | 1 |
Schuler, M | 1 |
Fletcher, JA | 1 |
Bauer, S | 1 |
1 other study available for vorinostat and Gastrointestinal Stromal Tumors
Article | Year |
---|---|
Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors.
Topics: Acetylation; Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; Gastrointestinal Stromal Tumors; Histon | 2009 |